IND Flu Vaccines Not Recommended For Routine Use, CDC Says
Executive Summary
Flu vaccines supplied under investigational new drug applications are not well-suited for routine use, a Centers for Disease Control & Prevention official told the National Vaccine Advisory Committee in Washington, D.C. June 7
You may also be interested in...
MedImmune Emerges As Potential Takeover Target With Vaccines, Synagis
MedImmune's growing vaccine franchise and recently revised co-marketing arrangement for Synagis (palivizumab) may position the firm well for a takeover
MedImmune Emerges As Potential Takeover Target With Vaccines, Synagis
MedImmune's growing vaccine franchise and recently revised co-marketing arrangement for Synagis (palivizumab) may position the firm well for a takeover
GSK Vaccine Portfolio Gets A Shot In The Arm From ID Biomedical Buy
GlaxoSmithKline's proposed acquisition of ID Biomedical, announced Sept. 7, will bolster the drug maker's growing vaccine portfolio with the addition of Fluviral and several pipeline products